V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20009015 | 20085344 | 1.82 | 79 | Palliative (P) | 2018-02-03 | 2018-02-11 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100938391 |
| 20009241 | 20085345 | 1.67 | 60.5 | Palliative (P) | 2019-06-25 | 2019-07-05 | Enzalutamide | 2 | N | CETUXIMAB | 100631812 |
| 20009305 | 20085346 | 1.58 | 134 | Neo-adjuvant (N) | 2018-01-30 | 2018-01-31 | Enzalutamide | 02 | N | CARBOPLATIN | 100737446 |
| 20009333 | 20085347 | 0 | 83 | Palliative (P) | 2019-06-27 | 2019-06-27 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100036913 |
| 20009420 | 20085348 | 0 | 0 | Curative (C) | 2018-12-09 | 2018-12-10 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101436095 |
| 20009627 | 20085349 | 1.77 | 75.4 | Curative (C) | null | 2019-12-03 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100512162 |
| 20009653 | 20085350 | 1.75 | 69 | Curative (C) | 2019-09-03 | 2019-09-07 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101343671 |
| 20009719 | 20085351 | 1.73 | 0 | Curative (C) | 2020-09-01 | 2020-09-02 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 100509456 |
| 20009732 | 20085352 | 1.73 | 67 | Curative (C) | 2020-06-10 | 2020-06-10 | Enzalutamide | 02 | Y | OCTREOTIDE | 100793126 |
| 20009794 | 20085353 | 1.77 | 87 | Curative (C) | 2019-09-22 | 2019-09-22 | Enzalutamide | 99 | N | CETUXIMAB + OXALIPLATIN + MDG | 100895023 |
| 20009918 | 20085354 | 1.69 | 78 | Palliative (P) | 2020-04-10 | 2020-04-18 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100910318 |
| 20010449 | 20085356 | 1.73 | 75.7 | Curative (C) | 2017-05-09 | 2017-05-09 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101046636 |
| 20010452 | 20085357 | 1.64 | 50.4 | null | 2018-04-23 | 2018-04-23 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100170700 |
| 20010545 | 20085359 | 1.63 | 71.6 | null | 2020-11-07 | 2020-11-11 | Enzalutamide | 1 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101812306 |
| 20010699 | 20085360 | 1.74 | 65 | Palliative (P) | 2017-08-15 | 2017-08-15 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100028975 |
| 20010742 | 20085362 | 1.67 | 90 | null | 2018-12-25 | 2019-01-19 | Enzalutamide | 99 | null | OXALIPLATIN + RALTITREXED | 100121458 |
| 20010900 | 20085364 | 1.72 | 88 | Curative (C) | 2020-01-31 | 2020-01-31 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101448105 |
| 20010911 | 20085365 | 1.7 | 128 | Palliative (P) | 2019-08-23 | 2019-09-07 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 101340964 |
| 20011155 | 20085367 | 1.57 | 72 | Curative (C) | 2020-06-18 | 2020-06-18 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100890131 |
| 20011393 | 20085368 | 1.73 | 106.5 | Palliative (P) | 2020-07-04 | 2020-08-15 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 100870582 |
| 20011423 | 20085370 | 1.73 | 52.3 | Palliative (P) | 2019-03-08 | 2019-03-22 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100434567 |
| 20011442 | 20085371 | 1.88 | 81.3 | Palliative (P) | 2017-01-08 | 2017-01-18 | Enzalutamide | null | N | SCALOP-2 TRIAL | 101289833 |
| 20011473 | 20085372 | 1.76 | null | Neo-adjuvant (N) | 2020-02-28 | 2020-03-05 | Enzalutamide | N | Y | TRASTUZUMAB | 100269900 |
| 20011556 | 20085373 | 1.54 | 97 | null | null | 2018-11-11 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100678008 |
| 20011580 | 20085374 | 1.88 | null | Palliative (P) | 2017-03-11 | 2017-03-18 | Enzalutamide | 02 | Y | LUTETIUM-177 | 100325417 |
| 20011768 | 20085376 | 1.79 | 72.35 | Curative (C) | 2019-04-01 | 2019-04-07 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100957306 |
| 20011804 | 20085377 | null | 0 | Palliative (P) | 2018-08-11 | 2018-08-22 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101231287 |
| 20011888 | 20085378 | 1.6 | 60.4 | null | 2019-08-26 | 2019-08-29 | Enzalutamide | 02 | null | CETUXIMAB | 100908581 |
| 20011920 | 20085380 | 1.83 | 72.8 | null | 2018-07-10 | 2018-07-23 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 100375811 |
| 20012209 | 20085383 | 0 | 0 | Curative (C) | 2020-09-11 | 2020-09-11 | Cisplatin | 02 | Y | SCALOP-2 TRIAL | 101659714 |
| 20012214 | 20085384 | 1.69 | 57 | Palliative (P) | 2019-07-16 | 2019-08-05 | ECF | 2 | N | ECF | 101080388 |
| 20012384 | 20085386 | 1.61 | 64 | Disease modification (D) | 2018-01-18 | 2018-01-19 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 100760648 |
| 20012412 | 20085387 | 1.77 | 63.7 | Palliative (P) | 2018-06-16 | 2018-06-16 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101539915 |
| 20012895 | 20085389 | 1.7 | 94.05 | Palliative (P) | 2019-07-29 | 2019-08-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 100157597 |
| 20013015 | 20085390 | 0 | 0 | Palliative (P) | 2019-09-08 | 2019-09-08 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100754360 |
| 20013044 | 20085391 | null | 76.8 | null | 2019-11-29 | 2019-11-29 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101156008 |
| 20013213 | 20085392 | 1.7 | 61.6 | Palliative (P) | 2019-01-11 | 2019-01-11 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101845907 |
| 20013259 | 20085393 | 1.77 | 57.2 | Palliative (P) | 2017-06-25 | 2017-07-08 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100229351 |
| 20013261 | 20085394 | 1.7 | 47.4 | Palliative (P) | 2022-01-24 | 2022-01-31 | Enzalutamide | 02 | N | CETUXIMAB | 100733431 |
| 20013346 | 20085396 | null | 99.7 | null | 2020-09-30 | 2020-09-30 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100553413 |
| 20013573 | 20085398 | 1.52 | 76.1 | Palliative (P) | 2019-09-07 | 2019-10-23 | Enzalutamide | 02 | N | CETUXIMAB | 100579573 |
| 20013723 | 20085399 | 1.72 | 85.3 | Curative (C) | 2020-03-07 | 2020-03-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101091820 |
| 20013935 | 20085400 | 1.6 | 61.4 | Adjuvant (A) | 2018-02-16 | 2018-02-24 | Trastuzumab 21 day loading dose | 2 | N | TRASTUZUMAB | 101349825 |
| 20013982 | 20085401 | 1.55 | 104 | Curative (C) | 2019-03-27 | 2019-03-27 | Enzalutamide | 02 | N | OCTREOTIDE | 101336351 |
| 20014159 | 20085402 | 1.72 | 47.1 | Palliative (P) | 2016-08-23 | 2016-08-23 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100003629 |
| 20014263 | 20085403 | 1.87 | 64.1 | null | 2015-09-09 | 2015-09-14 | Enzalutamide | null | null | CETUXIMAB + OXALIPLATIN + MDG | 101586112 |
| 20014490 | 20085405 | null | 64 | Neo-adjuvant (N) | 2021-01-25 | 2021-02-03 | Enzalutamide | 02 | N | OCTREOTIDE | 100788318 |
| 20014635 | 20085407 | 1.62 | 84.4 | Curative (C) | 2018-03-09 | 2018-03-09 | Enzalutamide | N | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101534670 |
| 20014703 | 20085408 | 1.73 | 70.5 | Palliative (P) | 2019-12-28 | 2020-01-12 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 101752532 |
| 20014761 | 20085409 | 1.69 | 112.6 | Palliative (P) | 2016-05-09 | 2016-05-29 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100214451 |